Join Now

Category Archives: Utah’s Life Sciences Companies

RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System

Salt Lake City-based RenalytixAI, today announced the commercial launch of the KidneyIntelX clinical test reporting platform within the Mount Sinai Health System. This means that KidneyIntelX risk assessment of progressive decline in kidney function or kidney failure, including education support for treating clinicians, is now commercially available for patients with early stage diabetic kidney disease […]

Also posted in BioUtah News, Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]

Also posted in BioUtah News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

BioFire Respiratory Panel with COVID Target Scores CE Mark

BioMerieux announced that Utah-based BioFire’s Respiratory Panel 2.1 plus, which tests for SARS-CoV-2 and 23 pathogens encompassing 19 viruses, and four bacteria that cause the most frequent respiratory tract infections, has received CE marking.  “It’s exciting to see the advances that BioFire is making in COVID-19 and infectious disease diagnostics,” said Kelvyn Cullimore, president and […]

Also posted in BioUtah News, Federal News, Industry News, Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

PhotoPharmics Stay-At-Home Trial for People with Parkinson’s

This week, PhotoPharmics announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial for the company’s Celeste® – a non-invasive, specialized light therapy device for Parkinson’s. The trial follows an FDA Breakthrough Device Designation for the device in […]

Also posted in BioUtah News, Federal News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

AdvaMed Request for Tariff Exclusions for Medical Technology Products

The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]

Also posted in COVID-19 Updates, Utah's Life Sciences Companies | | Leave a comment

Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

BioUtah COVID-19 Life Sciences Survey

TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including: Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state Indentifing funding sources from […]

Also posted in Life Sciences Industry News, State News, Utah's Life Sciences Companies | | Leave a comment

Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco

March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that recently reported it had received a CE marking for its COVID-19 coronavirus assay, announced today that it has been requested to speak at […]

Also posted in Life Sciences Events, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment